Evaluation of risks related to the use of adeno-associated virus-based vectors.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMID 14683451)

Published in Curr Gene Ther on December 01, 2003

Authors

L Tenenbaum1, E Lehtonen, P E Monahan

Author Affiliations

1: Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, ULB, Belgium. litenenb@ulb.ac.be

Articles citing this

DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J (2005) 2.03

Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy. Hepatology (2012) 1.59

Applications of viral nanoparticles in medicine. Curr Opin Biotechnol (2011) 1.49

Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol (2008) 1.33

Selective gene silencing by viral delivery of short hairpin RNA. Virol J (2010) 1.17

Long-term rescue of a lethal inherited disease by adeno-associated virus-mediated gene transfer in a mouse model of molybdenum-cofactor deficiency. Am J Hum Genet (2006) 1.12

A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res (2006) 1.08

Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage. Diabetes (2009) 1.08

Gene therapy for type I glycogen storage diseases. Curr Gene Ther (2007) 1.07

Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1. J Virol (2006) 1.06

A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting. Br J Clin Pharmacol (2013) 0.97

Transcriptional targeting of tumor endothelial cells for gene therapy. Adv Drug Deliv Rev (2009) 0.91

Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice. Gene Ther (2006) 0.89

Recombinant AAV-directed gene therapy for type I glycogen storage diseases. Expert Opin Biol Ther (2011) 0.85

Successful gene therapy in utero for lethal murine hypophosphatasia. Hum Gene Ther (2012) 0.84

Gene therapy for Parkinson's disease. Parkinsons Dis (2012) 0.83

Gene therapy: design and prospects for craniofacial regeneration. J Dent Res (2009) 0.83

Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors. Mol Ther (2008) 0.82

Adeno-associated Virus as a Mammalian DNA Vector. Microbiol Spectr (2015) 0.82

Neurogenethics: An emerging discipline at the intersection of ethics, neuroscience, and genomics. Appl Transl Genom (2015) 0.79

Assessment of hazard risk associated with the intravenous use of viral vectors in rodents. Comp Med (2012) 0.79

Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs. Gene Ther (2015) 0.78

Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells. Blood (2009) 0.78

Expression liver-directed genes by employing synthetic transcriptional control units. World J Gastroenterol (2005) 0.77

New aspects of gene-silencing for the treatment of cardiovascular diseases. Pharmaceuticals (Basel) (2013) 0.77

Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma. Biomed Res Int (2014) 0.77

Multiple recombinant adeno-associated viral vector serotypes display persistent in vivo gene expression in vector-transduced rat stifle joints. Hum Gene Ther Methods (2013) 0.77

Capsid protein expression and adeno-associated virus like particles assembly in Saccharomyces cerevisiae. Microb Cell Fact (2012) 0.76

A Novel, Real-Time, In Vivo Mouse Retinal Imaging System. Invest Ophthalmol Vis Sci (2015) 0.76

Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy. World J Gastroenterol (2016) 0.75

Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption. Sci Rep (2016) 0.75

Articles by these authors

(truncated to the top 100)

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther (2003) 4.92

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther (2001) 4.35

Expression of intermediate filaments in cultured cells. J Cell Sci (1981) 2.25

Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med (2004) 1.94

Rab17, a novel small GTPase, is specific for epithelial cells and is induced during cell polarization. J Cell Biol (1993) 1.86

Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc Natl Acad Sci U S A (1992) 1.76

Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors. Mol Ther (2001) 1.65

Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56

Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development (2000) 1.38

Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1. EMBO J (2001) 1.38

LFB1 and LFB3 homeoproteins are sequentially expressed during kidney development. Development (1992) 1.33

Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development (1995) 1.30

Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene Ther (2011) 1.24

Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol (1989) 1.23

Localization of cytoskeletal proteins in preimplantation mouse embryos. J Embryol Exp Morphol (1980) 1.23

Shift in collagen type as an early response to induction of the metanephric mesenchyme. J Cell Biol (1981) 1.22

Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells. J Cell Sci (1998) 1.16

A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech Dev (1998) 1.15

Transgene expression levels and kinetics determine risk of humoral immune response modeled in factor IX knockout and missense mutant mice. Gene Ther (2006) 1.12

Transfilter induction of kidney tubules as a function of the extent and duration of intercellular contacts. J Embryol Exp Morphol (1978) 1.10

Transfilter induction of kidney tubles: correlation with cytoplasmic penetration into nucleopore filters. J Embryol Exp Morphol (1974) 1.09

Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther (2003) 1.08

In vivo interaction of the adapter protein CD2-associated protein with the type 2 polycystic kidney disease protein, polycystin-2. J Biol Chem (2000) 1.08

Histogenesis of granular cell tumour--an immunohistochemical and ultrastructural study. J Pathol (1984) 1.08

Differentiation and vascularization of the metanephric kidney grafted on the chorioallantoic membrane. Dev Biol (1983) 1.06

A sec1-related vesicle-transport protein that is expressed predominantly in epithelial cells. Eur J Biochem (1996) 1.06

Assembly of the cardiac I-band region of titin/connectin: expression of the cardiac-specific regions and their structural relation to the elastic segments. J Muscle Res Cell Motil (1996) 1.04

Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplant (2001) 1.04

Embryonic kidney in organ culture. Differentiation (1987) 1.03

Formation and consequences of cell patterns in preimplantation mouse development. J Embryol Exp Morphol (1979) 1.02

Parietal and visceral endoderm differ in their expression of intermediate filaments. EMBO J (1983) 1.01

Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV. J Thromb Haemost (2009) 0.99

Kinetics of recombinant adeno-associated virus-mediated gene transfer. J Virol (2000) 0.98

Dendritic cells in human peripheral blood: effective enrichment from the nonadherent cells. Immunol Lett (1987) 0.97

Tranmission of signals in embryonic induction. Med Biol (1976) 0.95

HMG-17 is an early marker of inductive interactions in the developing mouse kidney. Differentiation (2001) 0.94

Sequential cell and tissue interactions governing organogenesis of the kidney. Anat Embryol (Berl) (1986) 0.93

Are morphogenetic tissue interactions mediated by transmissible signal substances or through cell contacts? Nature (1976) 0.92

Formation of vinculin plaques precedes other cytoskeletal changes during retinoic acid-induced teratocarcinoma cell differentiation. Exp Cell Res (1983) 0.92

Deformed spinal needle tips and associated dural perforations examined by scanning electron microscopy. Acta Anaesthesiol Scand (1996) 0.92

Changes in cell dimensions and intercellular contacts during cleavage-stage cell cycles in mouse embryonic cells. J Embryol Exp Morphol (1980) 0.91

Do membrane filters prevent cell contacts? Nature (1972) 0.90

Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector. Exp Neurol (2007) 0.90

Reorganization of intermediate filament cytoskeleton in induced metanephric mesenchyme cells is independent of tubule morphogenesis. Dev Biol (1985) 0.89

Interference of tooth differentiation with interposed filters. Dev Biol (1977) 0.89

Basement membrane formation in transfilter tooth culture and its relation to odontoblast differentiation. Differentiation (1978) 0.89

HMG-17, a chromosomal non-histone protein, shows developmental regulation during organogenesis. Int J Dev Biol (1998) 0.87

Visualization of human glomerular changes by scanning electron microscopy. Virchows Arch B Cell Pathol (1973) 0.87

Localization of growth differentiation factor-9 (GDF-9) mRNA and protein in rat ovaries and cDNA cloning of rat GDF-9 and its novel homolog GDF-9B. Mol Cell Endocrinol (1999) 0.87

Transcription factors GATA-4 and GATA-6 in human adrenocortical tumors. Endocr Res (2004) 0.87

Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy. Gene Ther (2011) 0.87

Demonstration of cytoplasmic processes in Millipore filters permitting kidney tubule induction. J Embryol Exp Morphol (1975) 0.86

Contact Nd:YAG laser potentiates the tumor cell killing effect of hyperthermia. Lasers Surg Med (1991) 0.86

Familial deficiency of vitamin K-dependent clotting factors. Haemophilia (2008) 0.85

Epithelio-mesenchymal interface during mouse kidney tubule induction in vivo. J Embryol Exp Morphol (1975) 0.83

Organization of intermediate filaments in cultured fibroblasts upon disruption of microtubules by cold treatment. Eur J Cell Biol (1980) 0.82

Toxicity of ethanol in low concentrations. Experimental evaluation in cell culture. Acta Radiol (1996) 0.82

Implanted solid human tumours grow under the renal capsule of cyclosporin-immunosuppressed rats. Scand J Immunol (1994) 0.82

Rhabdomyoma: ultrastructural features and distribution of desmin, muscle type of intermediate filament protein. Acta Pathol Microbiol Immunol Scand A (1982) 0.82

Exogenous fibronectin is not required for organogenesis in vitro. In Vitro (1983) 0.82

Syntaxin 3 and Munc-18-2 in epithelial cells during kidney development. Kidney Int (1999) 0.82

Neuron-like derivatives of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells. Dev Biol (1987) 0.81

The cytoskeleton and associated proteins during cleavage, compaction and blastocyst differentiation in the pig. Differentiation (1993) 0.80

gamma-Glutamyl transpeptidase in human amniotic fluid and in fetal tissues. Clin Chim Acta (1983) 0.80

Suppressor cells of the human NK activity: characterization of the cells and mechanism of action. Cell Immunol (1983) 0.80

Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database. Haemophilia (2013) 0.80

IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia. J Thromb Haemost (2013) 0.80

The parotid gland is the main source of human salivary epidermal growth factor. Life Sci (1988) 0.79

Spatiotemporal development of cochlear innervation and hair cell differentiation in the rat. Hear Res (1991) 0.79

A cloned human germ cell tumor-derived cell line differentiating in culture. Int J Cancer (1998) 0.79

Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond. Haemophilia (2012) 0.79

Changes in the distribution of vinculin during preimplantation mouse development. Differentiation (1986) 0.79

Vesicular transport and kidney development. Int J Dev Biol (1999) 0.78

The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel. Hum Reprod (1998) 0.78

Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide. Haemophilia (2004) 0.78

Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectors. Cell Transplant (2004) 0.78

Breast tumors with a solid and uniform carcinoid pattern. Ultrastructural and immunohistochemical study of two cases. Pathol Res Pract (1985) 0.78

Particulate fraction in amniotic fluid at second trimester. J Clin Pathol (1985) 0.77

Cell proliferation and expression of cytokeratin filaments in F9 embryonal carcinoma cells. Development (1989) 0.77

Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement. Haemophilia (2014) 0.77

Localization of nonerythroid spectrin and actin in mouse oocytes and preimplantation embryos. Differentiation (1985) 0.77

CS2 binding to rat spinal neurofilaments. Acta Neuropathol (1977) 0.77

Differential expression of gap junction mRNAs and proteins in the developing murine kidney and in experimentally induced nephric mesenchymes. Development (1992) 0.77

Distribution of F-actin and fodrin in the hair cells of the guinea pig cochlea as revealed by confocal fluorescence microscopy. Hear Res (1992) 0.77

Foreperiod and visual stimulus intensity: a reappraisal. Acta Psychol (Amst) (1982) 0.77

Neuroprotective gene therapy for Parkinson's disease. Curr Gene Ther (2002) 0.77

Expression of cytokeratin polypeptides in mouse oocytes and preimplantation embryos. Dev Biol (1983) 0.77

Dental papilla cells synthesize but do not deposit fibronectin in culture. J Dent Res (1987) 0.77

Embryonal carcinoma cells adhere preferentially to fibronectin and laminin but their endodermal differentiation leads to a reduced adherence to laminin. Exp Cell Res (1989) 0.76

The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells. Cell Regul (1991) 0.76

Mouse metanephric kidney as a model system for identifying developmentally regulated genes. J Cell Physiol (1997) 0.76

A monoclonal antibody against mouse oocyte cytoskeleton recognizing cytokeratin-type filaments. J Embryol Exp Morphol (1985) 0.76

Spinal cord-notochord relationship in normal human embryos and in a human embryo with double spinal cord. Acta Neuropathol (1993) 0.76

Morphological and immunohistochemical characteristics of axial structures in the transitory human tail. Ann Anat (1994) 0.75

Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, Argentina. Haemophilia (2010) 0.75

Modulation of fibroblast growth factor receptor expression and signalling during retinoic acid-induced differentiation of Tera-2 teratocarcinoma cells. Biochem Biophys Res Commun (1993) 0.75

A chondroitin sulfate epitope in mammalian dental pulp and its developmental expression in mouse dental papilla. J Dent Res (1993) 0.75

[A morphological study of the keratin cytoskeleton of the oocyte from the clawed toad using heterologous monoclonal antibodies]. Ontogenez (1994) 0.75

[3H]-adenine metabolism and radiation damage during in vitro development of the kidney. J Histochem Cytochem (1992) 0.75

Damage to multicellular human H-2 glioma spheroids incubated with LAK cells: an ultrastructural study. J Natl Cancer Inst (1990) 0.75